Orasure Technologies INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
OraSure Technologies reports a net loss for 2024, announces the acquisition of Sherlock Biosciences, and details strategic shifts in its business operations.
NASDAQ
OraSure Technologies reports a profitable 2023, driven by InteliSwab sales and cost management, while also detailing risks and future strategies in its annual 10-K filing.